Graham Capital Management
ACHV icon

Graham Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Graham Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-42,723
Closed -$212K – 1123
2025
Q4 		$212K Buy
+42,723
New +$186K 0.01% 1022

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Graham Capital Management's ACHV Position: Q1 2026 in Review

Graham Capital Management sold out of Achieve Life Sciences (ACHV) in Q1 2026, closing a stake of 42,723 shares — an estimated $212K sold.

Graham Capital Management first reported a position in ACHV in Q4 2025 and held it in 1 quarter. The position peaked at $212K in Q4 2025. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

  • Graham Capital Management reported no remaining Achieve Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Graham Capital Management sold 42,723 Achieve Life Sciences shares in Q1 2026, an estimated $212K.
  • Graham Capital Management first reported a position in Achieve Life Sciences in Q4 2025 and held it in 1 quarter.
  • Graham Capital Management's Achieve Life Sciences position peaked at $212K in Q4 2025.
  • 81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.